Our mission is to achieve positive outcomes for ischemic disorders.
Our work is inspired by the possibility, which to us appears imminent, that millions of people will recover from ischemic disorders who otherwise would die or endure debilitating diseases for the rest of their lives.
Karin Przyklenk, PhD, a member of our Board of Advisors, discovered Remote Ischemic Conditioning (RIC) therapy in 1990. A few years later Boris Leschinsky, our Chairman, developed a clinical rationale for RIC devices and began inventing key technology concepts to make the therapy practical.
In 2010, Boris founded LifeCuff Technologies, which he first named Infarct Reduction Technologies, Inc., to further develop and commercialize the technology. He built a team to develop the device composed of both engineers and experienced medical device entrepreneurs. The team personally funded initial development.
During 2012, development was halted for lack of funds.
In 2014, Tom Moore, Chairman and CEO, was introduced to run the company, prepare it for funding and reactivate fund-raising. He and the other executive team and board members provided additional funding.
Considerable development has taken place since then, and the company is currently raising additional funding, which will enable it to reach the market.
The company has a management team with exceptional experience.
Thomas E. Moore, Chairman and CEO, was formerly CEO of two publicly held biotech companies and, before that, President of Healthcare, Procter & Gamble.
Boris Leschinsky, PhD., Founder and CTO. Formerly, VP Technology, Datascope.
Abe Abramovich, Co-founder & Chief Engineering Officer, responsible for product development. Formerly, founder & Principal Consultant, ProMed Technologies; Director of Advanced Product Development, Datascope.
Kirk Garratt, MD, Chief Medical Officer. Also serves as Associate Director, Christiana Care Health System. Former Clinical Director of Interventional Cardiology, Lenox Hill Hospital, NYC.
Todd Greenwood, PhD, MPH, Director of Marketing, More than 20 years’ experience in healthcare marketing.
Eleanor Haas, Director of Investor Relations and Communications. More than 20 years experience.
The company has medical thought leaders as advisors.
Karin Przyklenk, PhD., Director, Cardiovascular Research Institute; Professor, Physiology & Emergency Medicine, Wayne State University.
William W. O’Neill, MD, Medical Director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit.
Charles V. Pollack, MD, Chair of Emergency Dept., U of Pennsylvania Hospital, Philadelphia.
Douglas M. Hansell, MD, Chief Physician Executive, Cheetah Medical; Former Chief Medical Officer, GE Healthcare.
David G. Armstrong, DPM, MD, PhD, Professor of Surgery and Director. Southwestern Academic Limb Salvage Alliance (SALSA) at Keck School of Medicine, USC
Board of Directors
- Thomas A. Moore, Chairman and CEO
- Boris Leschinsky, Founder and CTO
- Abe Abramovich, SVP and Chief Engineering Officer
- Kirk N. Garratt, MD, Chief Medical Officer
- Mark Abramovich, SVP of Strategy and Market Planning, Charles Jones